SETDB1 and hepatocellular carcinoma: Importantly, when focusing specifically on HCC tumor cells, SETDB1-positive cells exhibited significantly higher stem cell scores compared to SETDB1-negative counterparts (Fig. 7H, Wilcoxon p = 0.044), supporting the association between SETDB1 expression and enhanced stem-like properties in HCC liver cancer cells.